| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |